Northern Trust
PDLI

Northern Trust’s PDL BioPharma, Inc. PDLI Stock Holding History

Northern Trust’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,350,358
Closed -$13.7M – 4483
2020
Q3 		$13.7M Sell
4,350,358
-107,008
-2% -$342K ﹤0.01% 1902
2020
Q2 		$13M Buy
4,457,366
+32,915
+0.7% +$104K ﹤0.01% 1944
2020
Q1 		$12.5M Buy
4,424,451
+6,979
+0.2% +$22.5K ﹤0.01% 1737
2019
Q4 		$14.3M Sell
4,417,472
-63,101
-1% -$183K ﹤0.01% 1947
2019
Q3 		$9.68M Sell
4,480,573
-154,632
-3% -$413K ﹤0.01% 2169
2019
Q2 		$14.6M Sell
4,635,205
-53,749
-1% -$174K ﹤0.01% 1903
2019
Q1 		$17.4M Sell
4,688,954
-6,564
-0.1% -$22.2K ﹤0.01% 1793
2018
Q4 		$13.6M Sell
4,695,518
-15,412
-0.3% -$42.3K ﹤0.01% 1869
2018
Q3 		$12.4M Sell
4,710,930
-232,014
-5% -$569K ﹤0.01% 2134
2018
Q2 		$11.6M Sell
4,942,944
-31,004
-0.6% -$86.6K ﹤0.01% 2176
2018
Q1 		$14.6M Buy
4,973,948
+1,578,761
+46% +$4.31M ﹤0.01% 1919
2017
Q4 		$9.3M Buy
3,395,187
+69,417
+2% +$213K ﹤0.01% 2232
2017
Q3 		$11.3M Buy
3,325,770
+479,424
+17% +$1.33M ﹤0.01% 2128
2017
Q2 		$7.03M Buy
2,846,346
+931,730
+49% +$2.14M ﹤0.01% 2404
2017
Q1 		$4.35M Sell
1,914,616
-1,127,943
-37% -$2.5M ﹤0.01% 2636
2016
Q4 		$6.45M Buy
3,042,559
+81,534
+3% +$227K ﹤0.01% 2377
2016
Q3 		$9.92M Buy
2,961,025
+85,780
+3% +$272K ﹤0.01% 2087
2016
Q2 		$9.03M Buy
2,875,245
+46,378
+2% +$155K ﹤0.01% 2087
2016
Q1 		$9.42M Buy
2,828,867
+1,107,664
+64% +$3.45M ﹤0.01% 2011
2015
Q4 		$6.09M Buy
1,721,203
+38,796
+2% +$162K ﹤0.01% 2344
2015
Q3 		$8.46M Sell
1,682,407
-958,093
-36% -$5.49M ﹤0.01% 2111
2015
Q2 		$17M Sell
2,640,500
-43,079
-2% -$289K 0.01% 1713
2015
Q1 		$18.9M Buy
2,683,579
+47,218
+2% +$342K 0.01% 1629
2014
Q4 		$20.3M Sell
2,636,361
-49,696
-2% -$393K 0.01% 1531
2014
Q3 		$20.1M Buy
2,686,057
+13,112
+0.5% +$122K 0.01% 1510
2014
Q2 		$25.9M Buy
2,672,945
+33,998
+1% +$303K 0.01% 1311
2014
Q1 		$21.9M Sell
2,638,947
-494,518
-16% -$4.24M 0.01% 1496
2013
Q4 		$26.4M Buy
3,133,465
+454,569
+17% +$3.83M 0.01% 1292
2013
Q3 		$21.4M Sell
2,678,896
-251,956
-9% -$2.03M 0.01% 1412
2013
Q2 		$22.6M Buy
+2,930,852
New +$22.9M 0.01% 1279

Other funds holding PDLI

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $4.33B AUM 1.35% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Northern Trust's PDLI Position: Q4 2020 in Review

Northern Trust sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 4,350,358 shares — an estimated $13.7M sold.

Northern Trust first reported a position in PDLI in Q2 2013 and held it in 30 quarters. The position peaked at $26.4M in Q4 2013. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • Northern Trust reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • Northern Trust sold 4,350,358 PDL BioPharma, Inc. shares in Q4 2020, an estimated $13.7M.
  • Northern Trust first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 30 quarters.
  • Northern Trust's PDL BioPharma, Inc. position peaked at $26.4M in Q4 2013.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on Northern Trust's 13F filing for Q4 2020, filed 11 Feb 2021.